DOCSLIB.ORG

Prefrontal Α7nachr Signaling Differentially Modulates Afferent

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Prefrontal Α7nachr Signaling Differentially Modulates Afferent Research Articles: Systems/Circuits Prefrontal α7nAChR signaling differentially modulates afferent drive and trace fear conditioning behavior in adolescent and adult rats https://doi.org/10.1523/JNEUROSCI.1941-20.2020 Cite as: J. Neurosci 2021; 10.1523/JNEUROSCI.1941-20.2020 Received: 27 July 2020 Revised: 29 November 2020 Accepted: 23 December 2020 This Early Release article has been peer-reviewed and accepted, but has not been through the composition and copyediting processes. The final version may differ slightly in style or formatting and will contain links to any extended data. Alerts: Sign up at www.jneurosci.org/alerts to receive customized email alerts when the fully formatted version of this article is published. Copyright © 2021 the authors 1 Prefrontal α7nAChR signaling differentially modulates afferent drive 2 and trace fear conditioning behavior in adolescent and adult rats 3 4 5 6 7 Running title: Prefrontal α7nAChR control of afferent drive 8 9 10 11 Anabel M. M. Miguelez Fernandez, Hanna M. Molla, Daniel R. Thomases, and Kuei Y. Tseng* 12 13 Department of Anatomy and Cell Biology, University of Illinois at Chicago, IL 14 15 16 17 *Corresponding Author: Kuei Y. Tseng, MD, PhD 18 Department of Anatomy and Cell Biology 19 University of Illinois at Chicago – College of Medicine 20 Chicago, IL 60612, USA 21 Email: [email protected] 22 23 24 Number of figures: 8 25 Number of tables: 0 26 Abstract: 250 27 Main text: 4,030 words (Introduction: 451; Methods: 1,205; Results: 979; Discussion: 1,395) 28 29 30 31 32 Acknowledgements 33 Supported by NIH Grants R01-MH086507 and R01-MH105488 to KYT, and UIC College of Medicine 34 funds to KYT. We thank Dr. Adriana Caballero for thoughtful comments on the manuscript. This study 35 was initiated at Rosalind Franklin University – Chicago Medical School. 36 Miguelez Fernandez et al_Tseng 2020: α7nAChR_paper 1 37 Abstract 38 Increased level of kynurenic acid is thought to contribute to the development of cognitive deficits in 39 schizophrenia through an α7nAChR-mediated mechanism in the prefrontal cortex (PFC). Yet, it 40 remains unclear to what extent disruption of PFC α7nAChR signaling impacts afferent transmission and 41 its modulation of behavior. Here we found that PFC infusion of methyllycaconitine (MLA, α7nAChR 42 antagonist) shifts ventral hippocampal-induced local field potential (LFP) suppression to LFP facilitation, 43 an effect only observed in adult male rats. Hippocampal stimulation can also elicit a GluN2B-mediated 44 LFP potentiation (when PFC GABAAR is blocked) that is insensitive to MLA. Conversely, PFC infusion 45 of MLA diminished the gain of amygdalar transmission, which is already enabled by postnatal day 30. 46 Behaviorally, the impact of prefrontal MLA on trace fear-conditioning and extinction was also age- 47 related. While freezing behavior during conditioning was reduced by MLA only in adults, it elicited 48 opposite effects in adolescent and adult rats during extinction as revealed by the level of reduced and 49 increased freezing response, respectively. We next asked if the late-adolescent onset of α7nAChR 50 modulation of hippocampal inputs contributes to the age-dependent effect of MLA during extinction. 51 Data revealed that the increased freezing behavior elicited by MLA in adult rats could be driven by a 52 dysregulation of the GluN2B transmission in the PFC. Collectively, these results indicate that distinct 53 neural circuits are recruited during the extinction of trace fear memory in adolescents and adults, likely 54 due to the late-adolescent maturation of the ventral hippocampal-PFC functional connectivity and its 55 modulation by α7nAChR signaling. 56 57 58 Miguelez Fernandez et al_Tseng 2020: α7nAChR_paper 2 59 Significance statement 60 Abnormal elevation of the astrocyte-derived metabolite kynurenic acid in the prefrontal cortex is thought 61 to impair cognitive functions in schizophrenia through an α7nAChR-mediated mechanism. Here we 62 found that prefrontal α7nAChR signaling is recruited to control the gain of hippocampal and amygdalar 63 afferent transmission in an input-specific, age-related manner during the adolescent transition to 64 adulthood. Behaviorally, prefrontal α7nAChR modulation of trace fear memory was also age-related, 65 likely due to the late-adolescent maturation of the ventral hippocampal pathway and its recruitment of 66 PFC GABAergic transmission enabled by local α7nAChR signaling. Collectively, these results reveal 67 that distinct α7nAChR-sensitive neural circuits contribute to regulate behavior responses in adolescents 68 and adults, particularly those requiring proper integration of hippocampal and amygdalar inputs by the 69 prefrontal cortex. 70 Miguelez Fernandez et al_Tseng 2020: α7nAChR_paper 3 71 Introduction 72 Several neural processes contributing to prefrontal cortex (PFC) maturation undergo major remodeling 73 during adolescence (Caballero et al., 2016; Caballero and Tseng, 2016) to enable the acquisition of 74 adult cognitive abilities (Casey et al., 2000; Best and Miller, 2010). As PFC processing and integration 75 of inputs matures through adolescence (Caballero et al., 2016), any disruption that compromises the 76 protracted trajectory of prefrontal development is expected to confer vulnerability to the onset of mental 77 disorders (Caballero and Tseng, 2016) that display cognitive deficits and associated dysregulation of 78 affect (Paus et al., 2008; Gogtay et al., 2011; Volk and Lewis, 2014). Thus, elucidating which signaling 79 mechanisms are recruited to strengthen the functional connectivity of PFC afferent transmission is key 80 to reveal how cognitive impairments could emerge in psychiatric disorders when such recruitment fails 81 to occur (Caballero et al., 2016; Caballero and Tseng, 2016). 82 Of particular interest is the increased level of kynurenic acid in the PFC and its potential link to 83 the onset of cognitive deficits in schizophrenia (Erhardt et al., 2007; Wonodi and Schwarcz, 2010; 84 Myint, 2012). In addition to disrupting NMDAR function (Kessler et al., 1989; Parsons et al., 1997), 85 nanomolar concentrations of kynurenic acid can elicit a state of excitatory-inhibitory imbalance in the 86 PFC through a presynaptic α7nAChR-mediated mechanism (Flores-Barrera et al., 2017). Certainly, 87 prefrontal regulation of cognitive behavior, such as working memory, behavioral flexibility and attention, 88 requires proper levels of α7nAChR and NMDAR function (Alexander et al., 2012; Alexander et al., 89 2013; Phenis et al., 2020) and integration of hippocampal and amygdalar inputs by the PFC (Floresco 90 et al., 1997; Ishikawa and Nakamura, 2003; Tse et al., 2015). Since α7nAChRs are well-positioned to 91 regulate glutamate release in the PFC (Bortz et al., 2016), any disruption of local α7nAChR signaling is 92 expected to impact the gain of afferent glutamatergic transmission and the recruitment of postsynaptic 93 NMDAR-mediated plasticity by hippocampal and amygdalar inputs (Flores-Barrera et al., 2014). 94 The aim of the present study is to determine how disruption of α7nAChR signaling in the PFC 95 impacts afferent information processing and its control of behavioral responses in adolescent and adult Miguelez Fernandez et al_Tseng 2020: α7nAChR_paper 4 96 rats. To this end, local field potential recordings were combined with PFC infusions of antagonists to 97 reveal whether α7nAChR modulation of ventral hippocampal and basolateral amygdalar transmission is 98 input-specific and age-regulated between. Similar pharmacological manipulations were implemented to 99 assess the contribution of prefrontal α7nAChR signaling in modulating behavior using a trace fear 100 conditioning paradigm. Such a behavioral construct was preferred because proper processing of 101 hippocampal and amygdalar afferent information by the PFC is needed for the learning and extinction 102 of conditioned fear memories (Ishikawa and Nakamura, 2003; Sierra-Mercado et al., 2011; Gilmartin et 103 al., 2012; Sotres-Bayon et al., 2012; Gilmartin et al., 2014). Miguelez Fernandez et al_Tseng 2020: α7nAChR_paper 5 104 Materials and Methods 105 All experimental procedures were approved by the University of Illinois at Chicago Institutional Animal 106 Care and Use Committee and met the National Institutes of Health guidelines for care and use of 107 laboratory animals. Male Sprague Dawley rats were purchased from Envigo. Upon arrival, rats were 108 allowed to habituate for at least 7 days before being subjected to any surgical procedures. They were 109 group housed (2-3 rats/cage), maintained under constant temperature (21-23°C) and light/dark cycle 110 (14/10hs) with food and water available ad libitum. All chemicals were obtained from Sigma, except for 111 methyllycaconitine (MLA) and Indiplon that were obtained from Tocris. 112 113 In vivo recordings of local field potential (LFP) responses in the prefrontal cortex (PFC). All recordings 114 and PFC infusions procedures were conducted as previously described (Cass et al., 2013; Thomases 115 et al., 2013; Caballero et al., 2014b; Thomases et al., 2014). Briefly, rats were anesthetized with 8% 116 chloral hydrate (400mg/kg, i.p.), placed in a stereotaxic frame, and maintained at 37-38°C with a steady 117 supplement of 300-400 μL/hour of 8% chloral hydrate. After exposing the skull, two burr holes were 118 drilled to place the recording electrode in the medial PFC and the stimulating electrode within the 119 ventral hippocampus or the basolateral amygdala. All LFP recordings were obtained using a concentric 120 bipolar electrode attached to a 28G cannula (PlasticsOne), amplified (Cygnus Technology), filtered (1– 121 100 Hz bandwidth), and digitized (Digidata 1440A, Molecular Devices) at a sampling rate of 10 kHz. 122 The intensity of stimulation was chosen from the 0.2–0.8 mA range (mean intensity: ~0.6mA) using 300 123 μs duration square pulses delivered every 15 s through a computer-controlled pulse generator (Master 124 8, A.M.P.I.). Typically, a 10 min LFP baseline recording was collected prior PFC infusions of 0.8 μL (0.1 125 μL/min) artificial cerebrospinal fluid (aCSF)-containing vehicle, picrotoxin (50μM in 0.1% DMSO), MLA 126 (300nM) or picrotoxin + MLA.
Load more

Recommended publications
  • Nicotinic Stimulation Produces Multiple Forms of Increased Glutamatergic Synaptic Transmission
    The Journal of Neuroscience, September 15, 1998, 18(18):7075–7083 Nicotinic Stimulation Produces Multiple Forms of Increased Glutamatergic Synaptic Transmission Kristofer A. Radcliffe and John A. Dani Division of Neuroscience, Baylor College of Medicine, Houston, Texas 77030-3498 Synaptic modulation and long-term synaptic changes are initiate calcium-dependent mechanisms that are known to in- thought to be the cellular correlates for learning and memory duce glutamatergic synaptic plasticity. The results with evoked (Madison et al., 1991; Aiba et al., 1994; Goda and Stevens, synaptic currents showed that nAChR activity can alter the 1996). The hippocampus is a center for learning and memory relationship between the incoming presynaptic activity and that receives abundant cholinergic innervation and has a high outgoing postsynaptic signaling along glutamatergic fibers. density of nicotinic acetylcholine receptors (nAChRs) (Wada et Thus, the same information arriving along the same glutama- al., 1989; Woolf, 1991). We report that strong, brief stimulation tergic afferents will be processed differently when properly of nAChRs enhanced hippocampal glutamatergic synaptic timed nicotinic activity converges onto the glutamatergic pre- transmission on two independent time scales and altered the synaptic terminals. Influencing information processing at gluta- relationship between consecutively evoked synaptic currents. matergic synapses may be one way in which nicotinic cholin- The nicotinic synaptic enhancement required extracellular cal- ergic activity influences cognitive processes. Disruption of cium and was produced by the activation of presynaptic a7- these nicotinic cholinergic mechanisms may contribute to the containing nAChRs. Although one form of glutamatergic en- deficits associated with the degeneration of cholinergic func- hancement lasted only for seconds, another form lasted for tions during Alzheimer’s disease.
    [Show full text]
  • Drug Class Review Newer Drugs for Insomnia
    Drug Class Review Newer Drugs for Insomnia Final Update 2 Report October 2008 The Agency for Healthcare Research and Quality has not yet seen or approved this report. The purpose of Drug Effectiveness Review Project reports is to make available information regarding the comparative clinical effectiveness and harms of different drugs. Reports are not usage guidelines, nor should they be read as an endorsement of or recommendation for any particular drug, use, or approach. Oregon Health & Science University does not recommend or endorse any guideline or recommendation developed by users of these reports. Update 1: July 2006 Original: December 2005 Susan Carson, MPH Marian S. McDonagh, PharmD Sujata Thakurta, MPA:HA Po-Yin Yen, MS Drug Effectiveness Review Project Marian McDonagh, PharmD, Principal Investigator Oregon Evidence-based Practice Center Mark Helfand, MD, MPH, Director Copyright © 2008 by Oregon Health & Science University Portland, Oregon 97239. All rights reserved. Final Report Update 2 Drug Effectiveness Review Project The medical literature relating to the topic is scanned periodically (see http://www.ohsu.edu/xd/research/centers-institutes/evidence-based-policy- center/derp/documents/methods.cfm for scanning process description). Upon review of the last scan, the Drug Effectiveness Review Project governance group elected not to proceed with another full update of this report based on the information contained in the scan. Some portions of the report may not be up to date. Prior versions of this report can be accessed at the DERP website. Insomnia Page 2 of 87 Final Report Update 2 Drug Effectiveness Review Project TABLE OF CONTENTS INTRODUCTION ............................................................................................................. 6 Scope and Key Questions ......................................................................................................................
    [Show full text]
  • GABA Receptors
    D Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews Review No.7 / 1-2011 GABA receptors Wolfgang Froestl , CNS & Chemistry Expert, AC Immune SA, PSE Building B - EPFL, CH-1015 Lausanne, Phone: +41 21 693 91 43, FAX: +41 21 693 91 20, E-mail: [email protected] GABA Activation of the GABA A receptor leads to an influx of chloride GABA ( -aminobutyric acid; Figure 1) is the most important and ions and to a hyperpolarization of the membrane. 16 subunits with γ most abundant inhibitory neurotransmitter in the mammalian molecular weights between 50 and 65 kD have been identified brain 1,2 , where it was first discovered in 1950 3-5 . It is a small achiral so far, 6 subunits, 3 subunits, 3 subunits, and the , , α β γ δ ε θ molecule with molecular weight of 103 g/mol and high water solu - and subunits 8,9 . π bility. At 25°C one gram of water can dissolve 1.3 grams of GABA. 2 Such a hydrophilic molecule (log P = -2.13, PSA = 63.3 Å ) cannot In the meantime all GABA A receptor binding sites have been eluci - cross the blood brain barrier. It is produced in the brain by decarb- dated in great detail. The GABA site is located at the interface oxylation of L-glutamic acid by the enzyme glutamic acid decarb- between and subunits. Benzodiazepines interact with subunit α β oxylase (GAD, EC 4.1.1.15). It is a neutral amino acid with pK = combinations ( ) ( ) , which is the most abundant combi - 1 α1 2 β2 2 γ2 4.23 and pK = 10.43.
    [Show full text]
  • Neuronal Nicotinic Receptors: from Structure to Pathology
    Progress in Neurobiology 74 (2004) 363–396 www.elsevier.com/locate/pneurobio Neuronal nicotinic receptors: from structure to pathology C. Gotti, F. Clementi* CNR, Institute of Neuroscience, Cellular and Molecular Pharmacology Section, Department of Medical Pharmacology and Center of Excellence on Neurodegenerative Diseases, University of Milan, Via Vanvitelli 32, 20129 Milan, Italy Received 22 July 2004; accepted 29 September 2004 Available online 27 October 2004 Abstract Neuronal nicotinic receptors (NAChRs) form a heterogeneous family of ion channels that are differently expressed in many regions of the central nervous system (CNS) and peripheral nervous system. These different receptor subtypes, which have characteristic pharmacological and biophysical properties, have a pentameric structure consisting of the homomeric or heteromeric combination of 12 different subunits (a2–a10, b2–b4). By responding to the endogenous neurotransmitter acetylcholine, NAChRs contribute to a wide range of brain activities and influence a number of physiological functions. Furthermore, it is becoming evident that the perturbation of cholinergic nicotinic neurotransmission can lead to various diseases involving nAChR dysfunction during development, adulthood and ageing. In recent years, it has been discovered that NAChRs are present in a number of non-neuronal cells where they play a significant functional role and are the pathogenetic targets in several diseases. NAChRs are also the target of natural ligands and toxins including nicotine (Nic), the most widespread drug of abuse. This review will attempt to survey the major achievements reached in the study of the structure and function of NAChRs by examining their regional and cellular localisation and the molecular basis of their functional diversity mainly in pharmacological and biochemical terms.
    [Show full text]
  • Alkaloids Pp. 178-End.Pdf
    Hydrastine Found in the roots and rhizomes of Hydrastis canadensis (family: Ranunculaceae). Uses: To control uterine hemorrhage. Traditional use of this root as: 1. Tonic {a medicine that strengthens). Abusamra Yousef Dr. 2. Uterine hemorrhage. 3. Catarrhal conditions. 178 Berberine: Berberies species) and)البرباريسية From Berberidaceae . .(Hydrastis)الفصيلة ال َح ْوذانية Ranunculaceae . Used as antiemetic, antibacterial and anti-inflammatory. Also, it is used for liver diseases. Sanguinarine: blood) دموية From the roots of Sanguinaria canadensis . Dr. Yousef Abusamra Yousef Dr. root) {Family Papaveraceae}. Native to America. Its effect resembles colchicine, i.e. causes doubling of chromosomes number (polyploidy). 179 . Used for atonic dyspepsia with hepatic symptoms. عسر الهضم Jatrorrhizine A protoberberine Benefits: alkaloid Antifungal, antibacterial, Antidiabetic, antiinflammatory. Dr. Yousef Abusamra Yousef Dr. Berberine 180 A quaternary amine alkaloid. Hydrastine Curare alkaloids: Bis-benzylisoquinoline. obtained from the bark and stems of Chondrodendrum tomentosum (family: Menispermaceae). The name is derived from “urari”; an Indian word indicating “poison”. The term “curare” is used to indicate the crude extract prepared from different species. Abusamra Yousef Dr. Was used by certain natives of the Amazon regions of South America as arrow poison. Some of these extracts were poisonous by virtue of a convulsant action and 181 others by paralyzing action (Most remarkable). Mechanism of action of d-tubocurarine Dr. Yousef Abusamra Yousef Dr. 182 • Curare possesses: 1. A paralyzing effect on voluntary muscles. 2. A toxic effect on blood vessels. 3. A histamine–like effect. Most of the activity is attributed to d-tubocurarine. Uses: 1- In surgical anesthesia, as it produces muscular relaxation without deep anesthesia.
    [Show full text]
  • Hypnotic Drug Risks of Mortality, Infection, Depression, and Cancer: but Lack of Benefit [Version 3; Peer Review: 2 Approved]
    F1000Research 2018, 5:918 Last updated: 03 AUG 2021 REVIEW Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit [version 3; peer review: 2 approved] Daniel F. Kripke University of California, San Diego, La Jolla, CA, 92037-2226, USA v3 First published: 19 May 2016, 5:918 Open Peer Review https://doi.org/10.12688/f1000research.8729.1 Second version: 17 Mar 2017, 5:918 https://doi.org/10.12688/f1000research.8729.2 Reviewer Status Latest published: 12 Nov 2018, 5:918 https://doi.org/10.12688/f1000research.8729.3 Invited Reviewers 1 2 Abstract This is a review of hypnotic drug risks and benefits. Almost every version 3 month, new information appears about the risks of hypnotics (update) report report (sleeping pills). The most important risks of hypnotics include excess 12 Nov 2018 mortality (especially overdose deaths, quiet deaths at night, and suicides), infections, cancer, depression, automobile crashes, falls, version 2 other accidents, and hypnotic-withdrawal insomnia. Short-term use of (update) report one-two prescriptions is associated with even greater risk per dose 17 Mar 2017 than long-term use. Hypnotics have usually been prescribed without approved indication, most often with specific contraindications, but version 1 even when indicated, there is little or no benefit. The recommended 19 May 2016 report report doses objectively increase sleep little if at all, daytime performance is often made worse (not better) and the lack of general health benefits is commonly misrepresented in advertising. Treatments such as the 1. Jerome M. Siegel, University of cognitive behavioral treatment of insomnia and bright light treatment California, Los Angeles, Los Angeles, USA of circadian rhythm disorders offer safer and more effective alternative approaches to insomnia.
    [Show full text]
  • Differing Time Dependencies of Object Recognition Memory Impairments Produced by Nicotinic and Muscarinic Cholinergic Antagonism in Perirhinal Cortex
    Downloaded from learnmem.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press Research Differing time dependencies of object recognition memory impairments produced by nicotinic and muscarinic cholinergic antagonism in perirhinal cortex Chris J. Tinsley,1,3 Nadine S. Fontaine-Palmer,1 Maria Vincent,1 Emma P.E. Endean,1 John P. Aggleton,2 Malcolm W. Brown,1 and E. Clea Warburton1 1MRC Centre for Synaptic Plasticity, School of Physiological Sciences, Bristol University, Bristol BS8 1TD, United Kingdom; 2School of Psychology, Cardiff University, Cardiff CF10 3AT, United Kingdom The roles of muscarinic and nicotinic cholinergic receptors in perirhinal cortex in object recognition memory were com- pared. Rats’ discrimination of a novel object preference test (NOP) test was measured after either systemic or local infusion into the perirhinal cortex of the nicotinic receptor antagonist methyllycaconitine (MLA), which targets alpha-7 (a7) amongst other nicotinic receptors or the muscarinic receptor antagonists scopolamine, AFDX-384, and pirenzepine. Methyllycaconitine administered systemically or intraperirhinally before acquisition impaired recognition memory tested after a 24-h, but not a 20-min delay. In contrast, all three muscarinic antagonists produced a similar, unusual pattern of impairment with amnesia after a 20-min delay, but remembrance after a 24-h delay. Thus, the amnesic effects of nicotinic and muscarinic antagonism were doubly dissociated across the 20-min and 24-h delays. The same pattern of shorter-term but not longer-term memory impairment was found for scopolamine whether the object preference test was carried out in a square arena or a Y-maze and whether rats of the Dark Agouti or Lister-hooded strains were used.
    [Show full text]
  • Neuronal Nicotinic Receptors
    NEURONAL NICOTINIC RECEPTORS Dr Christopher G V Sharples and preparations lend themselves to physiological and pharmacological investigations, and there followed a Professor Susan Wonnacott period of intense study of the properties of nAChR- mediating transmission at these sites. nAChRs at the Department of Biology and Biochemistry, muscle endplate and in sympathetic ganglia could be University of Bath, Bath BA2 7AY, UK distinguished by their respective preferences for C10 and C6 polymethylene bistrimethylammonium Susan Wonnacott is Professor of compounds, notably decamethonium and Neuroscience and Christopher Sharples is a hexamethonium,5 providing the first hint of diversity post-doctoral research officer within the among nAChRs. Department of Biology and Biochemistry at Biochemical approaches to elucidate the structure the University of Bath. Their research and function of the nAChR protein in the 1970’s were focuses on understanding the molecular and facilitated by the abundance of nicotinic synapses cellular events underlying the effects of akin to the muscle endplate, in electric organs of the acute and chronic nicotinic receptor electric ray,Torpedo , and eel, Electrophorus . High stimulation. This is with the goal of affinity snakea -toxins, principallyaa -bungarotoxin ( - Bgt), enabled the nAChR protein to be purified, and elucidating the structure, function and subsequently resolved into 4 different subunits regulation of neuronal nicotinic receptors. designateda ,bg , and d .6 An additional subunit, e , was subsequently identified in adult muscle. In the early 1980’s, these subunits were cloned and sequenced, The nicotinic acetylcholine receptor (nAChR) arguably and the era of the molecular analysis of the nAChR has the longest history of experimental study of any commenced.
    [Show full text]
  • Nociceptive Thresholds Are Controlled Through Spinal ОІ2-Subunit
    PAINÒ 152 (2011) 2131–2137 www.elsevier.com/locate/pain Nociceptive thresholds are controlled through spinal b2-subunit-containing nicotinic acetylcholine receptors Ipek Yalcin a, Alexandre Charlet a,b, Matilde Cordero-Erausquin a, Luc-Henri Tessier a, Marina R. Picciotto c, ⇑ Rémy Schlichter a,b, Pierrick Poisbeau a,b, Marie-José Freund-Mercier a,b, Michel Barrot a, a Institut des Neurosciences Cellulaires et Intégratives, Centre National de la Recherche Scientifique, Strasbourg, France b Faculté des Sciences de la Vie, Université de Strasbourg, Strasbourg, France c Division of Molecular Psychiatry, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Yale University School of Medicine, New Haven, CT, USA Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. article info abstract Article history: Although cholinergic drugs are known to modulate nociception, the role of endogenous acetylcholine in Received 13 October 2010 nociceptive processing remains unclear. In the current study, we evaluated the role of cholinergic trans- Received in revised form 8 April 2011 mission through spinal b2-subunit-containing nicotinic acetylcholine receptors in the control of nocicep- Accepted 8 May 2011 tive thresholds. We show that mechanical and thermal nociceptive thresholds are significantly lowered ⁄ ⁄ in b2 -knockout (KO) mice. Using nicotinic antagonists in these mice, we demonstrate that b2 -nAChRs are responsible for tonic inhibitory control of mechanical thresholds at the spinal level. We further Keywords: hypothesized that tonic b ⁄-nAChR control of mechanical nociceptive thresholds might implicate GAB- Nicotinic 2 Aergic transmission since spinal nAChR stimulation can enhance inhibitory transmission. Indeed, the b -nAChRs 2 ⁄ Acetylcholine GABAA receptor antagonist bicuculline decreased the mechanical threshold in wild-type but not b2 -KO ⁄ ⁄ GABA mice, and the agonist muscimol restored basal mechanical threshold in b2 -KO mice.
    [Show full text]
  • Early Life Stress, Nicotinic Acetylcholine Receptors and Alcohol Use Disorders
    Brain Sci. 2015, 5, 258-274; doi:10.3390/brainsci5030258 OPEN ACCESS brain sciences ISSN 2076-3425 www.mdpi.com/journal/brainsci/ Review Early Life Stress, Nicotinic Acetylcholine Receptors and Alcohol Use Disorders Joan Y. Holgate * and Selena E. Bartlett Institute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of Technology, 37 Kent St, Woolloongabba, Queensland 4102, Australia; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +61-7-3443-7285; Fax: +61-7-3443-7779. Academic Editor: Marcelo Febo Received: 15 April 2015 / Accepted: 18 June 2015 / Published: 30 June 2015 Abstract: Stress is a major driving force in alcohol use disorders (AUDs). It influences how much one consumes, craving intensity and whether an abstinent individual will return to harmful alcohol consumption. We are most vulnerable to the effects of stress during early development, and exposure to multiple traumatic early life events dramatically increases the risk for AUDs. However, not everyone exposed to early life stress will develop an AUD. The mechanisms determining whether an individual’s brain adapts and becomes resilient to the effects of stress or succumbs and is unable to cope with stress remain elusive. Emerging evidence suggests that neuroplastic changes in the nucleus accumbens (NAc) following early life stress underlie the development of AUDs. This review discusses the impact of early life stress on NAc structure and function, how these changes affect cholinergic signaling within the mesolimbic reward pathway and the role nicotinic acetylcholine receptors (nAChRs) play in this process.
    [Show full text]
  • Belsomra: a First Look Sleep Medicine’S Newest Addition Has a Novel Mechanism and an Undecided Future
    COVER FOCUS Belsomra: A First Look Sleep medicine’s newest addition has a novel mechanism and an undecided future. BY ZAC HAUGHN, SENIOR ASSOCIATE EDITOR n the early 2000s, investment analysts anticipated a boom THE LITERATURE in the insomnia drug market.1 Indiplon and ramelt- The FDA considered Belsomra effective after it was eon (Rozerem) were on the verge of release, and Serpacor studied in three clinical trials involving more than 500 par- was testing eszopiclone, a nonbenzodiazepine hypnotic ticipants. In the studies, patients taking the drug fell asleep Iagent that a glowing “luna moth” would introduce to the faster and spent less time awake during the remainder of public as Lunesta in one of the most memorable pharma- the night compared to people taking placebo.4 The Agency ceutical ad campaigns in recent history. noted Belsomra was not compared to other drugs approved Despite Lunesta’s success and Rozerem’s approval, the to treat insomnia, so it is unknown if there are differences in anticipated boom was barely audible. Indiplon fizzled out safety or effectiveness between Belsomra and other insom- and the FDA made more sleep medicine headlines for rolling nia medications. back dosing than rolling out approvals. All of which makes The trials included two similarly designed, three-month, their recent approval of suvorexant (Belsomra) more intrigu- randomized, double-blind, placebo-controlled, parallel- ing: the oral drug is a substantially different product. group studies. Researchers examined Belsomra 20 and 40mg New to pharmacy shelves in early 2015, Belsomra is indi- in patients in non-elderly adults (age < 65 years) and 15 and cated for the treatment of insomnia characterized by dif- 30mg in elderly patients (age ≥ 65 years).2 Belsomra was ficulties with sleep onset and/or sleep maintenance in four superior to placebo for sleep latency as assessed both objec- different strengths: 5, 10, 15, and 20 milligrams; it is contra- tively by polysomnography and subjectively by patient-esti- indicated in patients with narcolepsy.
    [Show full text]
  • Foods, Drugs, Oils, and Compounds Chapter 198 1
    Foods, Drugs, Oils, and Compounds Chapter 198 1 FOODS, DRUGS, OILS, AND COMPOUNDS CHAPTER 198 SENATE BILL NO. 2218 (Senators J. Lee, Kilzer, Robinson) (Representatives Glassheim, N. Johnson, R. Kelsch) AN ACT to create and enact a new section to chapter 19-02.1 and section 19-03.1-22.4 of the North Dakota Century Code, relating to requirements for prescribing and dispensing controlled substances and certain other specified drugs and requirements for dispensing controlled substances by means of the internet; to amend and reenact subsection 2 of section 19-02.1-15 and section 19-03.1-23 of the North Dakota Century Code, relating to the exclusion from the exemption for dispensing certain drugs and penalties for unlawful distribution or dispensing of controlled substances and counterfeit controlled substances by means of the internet; and to provide a penalty. BE IT ENACTED BY THE LEGISLATIVE ASSEMBLY OF NORTH DAKOTA: SECTION 1. A new section to chapter 19-02.1 of the North Dakota Century Code is created and enacted as follows: Requirements for dispensing controlled substances and specified drugs - Penalty. 1. As used in this section: a. "Controlled substance" has the meaning set forth in section 19-03.1-01. b. "In-person medical evaluation" means a medical evaluation that is conducted with the patient in the physical presence of the practitioner, without regard to whether portions of the evaluation are conducted by other practitioners, and must include one of the following actions: (1) The prescribing practitioner examines the patient at
    [Show full text]